[1]
N. Friedmann, PhD, MD, M. R. Marsman, PharmD, A. W. de Kater, PhD, L. H. Burns, PhD, and L. R. Webster, MD, “A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation”, J of Opioid Management, vol. 14, no. 6, pp. 437–443, Nov. 2018.